Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Bexxar tositumomab: Began Phase II trial

Separately, the partners completed enrollment in a Phase II trial of Bexxar as first-line treatment of

Read the full 160 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE